By Professor Michael Proinsias Farrell

Journal articles

Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M; Treloar C, 2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389

Guillaumier A; Skelton E; Shakeshaft A; Farrell M; Tzelepis F; Walsberger S; D'Este C; Paul C; Dunlop A; Stirling R; Fowlie C; Kelly P; Oldmeadow C; Palazzi K; Bonevski B, 2020, 'Effect of increasing the delivery of smoking cessation care in alcohol and other drug treatment centres: a cluster-randomized controlled trial', Addiction, 115, pp. 1345 - 1355, http://dx.doi.org/10.1111/add.14911

Larance B; Degenhardt L; Grebely J; Nielsen S; Bruno R; Dietze P; Lancaster K; Larney S; Santo T; Shanahan M; Memedovic S; Ali R; Farrell M, 2020, 'Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia', Addiction, 115, pp. 1295 - 1305, http://dx.doi.org/10.1111/add.14941

Bórquez A; Rich K; Farrell M; Degenhardt L; McKetin R; Tran LT; Cepeda J; Silva-Santisteban A; Konda K; Cáceres CF; Kelly S; Altice FL; Martin NK, 2020, 'Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study', Journal of the International AIDS Society, 23, http://dx.doi.org/10.1002/jia2.25495

Darke S; Duflou J; Farrell M; Peacock A; Lappin J, 2020, 'Characteristics and circumstances of synthetic cannabinoid-related death', Clinical Toxicology, 58, pp. 368 - 374, http://dx.doi.org/10.1080/15563650.2019.1647344

Quinn B; Pearson R; Cutts J; Seed C; Scott N; Hoad V; Dietze P; Wilson D; Maher L; Thompson A; Farrell M; Harrod M; Caris S; Pink J; Kotsiou G; Hellard M, 2020, 'Blood donation amongst people who inject drugs in Australia: research supporting policy change', Vox Sanguinis, 115, pp. 162 - 170, http://dx.doi.org/10.1111/vox.12891

Farrell M; Robertson R, 2020, 'Commentary on Ho et al. (2020): Managing people with HIV and drug problems is complex and multi-faceted', Addiction, 115, pp. 653 - 654, http://dx.doi.org/10.1111/add.14950

Black N; Campbell G; Tran LT; Farrell M; Hall W; Degenhardt L, 2020, 'Cannabinoids for the treatment of mental disorders – Author's reply', The Lancet Psychiatry, 7, pp. 127 - 128, http://dx.doi.org/10.1016/S2215-0366(19)30526-7

Colledge S; Larney S; Peacock A; Leung J; Hickman M; Grebely J; Farrell M; Degenhardt L, 2020, 'Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: A systematic review and meta-analysis', Drug and Alcohol Dependence, 207, http://dx.doi.org/10.1016/j.drugalcdep.2019.107793

Farrell M; Clarke G; Barr G; Hannon J, 2020, 'Monitoring of prenatal patients using a combined antibody titre for Rh and non-Rh antibodies', TRANSFUSION MEDICINE, 30, pp. 210 - 214, http://dx.doi.org/10.1111/tme.12661

Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L, 2020, 'Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia', Substance Abuse, 41, pp. 139 - 145, http://dx.doi.org/10.1080/08897077.2019.1635954

Nielsen S; Picco L; Campbell G; Lintzeris N; Larance B; Farrell M; Degenhardt L; Bruno R, 2020, 'Development of a brief patient-administered screening tool for prescription opioid dependence for primary care settings', Pain Medicine (United States), 21, pp. E79 - E88, http://dx.doi.org/10.1093/pm/pnz213

Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.', Drug Alcohol Depend, 206, pp. 107697, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697

Fischer B; Daldegan-Bueno D; Bell R; Boden JM; Bullen C; Farrell M; Hall W; Newcombe D, 2020, 'The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand.', Public Health Pract (Oxf), 1, pp. 100046, http://dx.doi.org/10.1016/j.puhip.2020.100046

Suerink M; Rodríguez-Girondo M; van der Klift HM; Colas C; Brugieres L; Lavoine N; Jongmans M; Munar GC; Evans DG; Farrell MP; Genuardi M; Goldberg Y; Gomez-Garcia E; Heinimann K; Hoell JI; Aretz S; Jasperson KW; Kedar I; Modi MB; Nikolaev S; van Os TAM; Ripperger T; Rueda D; Senter L; Sjursen W; Sunde L; Therkildsen C; Tibiletti MG; Trainer AH; Vos YJ; Wagner A; Winship I; Wimmer K; Zimmermann SY; Vasen HF; van Asperen CJ; Houwing-Duistermaat JJ; ten Broeke SW; Nielsen M, 2019, 'An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome', Genetics in Medicine, 21, pp. 2706 - 2712, http://dx.doi.org/10.1038/s41436-019-0577-z

Gisev N; Nielsen S; Campbell G; Santo T; Mant A; Bruno R; Cohen M; Hall WD; Larance B; Lintzeris N; Farrell M; Degenhardt L, 2019, 'Antidepressant Use among People Prescribed Opioids for Chronic Noncancer Pain', Pain Medicine (United States), 20, pp. 2450 - 2458, http://dx.doi.org/10.1093/pm/pnz009

Black N; Stockings E; Campbell G; Tran LT; Zagic D; Hall WD; Farrell M; Degenhardt L, 2019, 'Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis', The Lancet Psychiatry, 6, pp. 995 - 1010, http://dx.doi.org/10.1016/S2215-0366(19)30401-8

Ma J; Bao YP; Wang RJ; Su MF; Liu MX; Li JQ; Degenhardt L; Farrell M; Blow FC; Ilgen M; Shi J; Lu L, 2019, 'Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis', Molecular Psychiatry, 24, pp. 1868 - 1883, http://dx.doi.org/10.1038/s41380-018-0094-5

Peacock A; Bruno R; Gisev N; Degenhardt L; Hall W; Sedefov R; White J; Thomas KV; Farrell M; Griffiths P, 2019, 'New psychoactive substances: challenges for drug surveillance, control, and public health responses', The Lancet, 394, pp. 1668 - 1684, http://dx.doi.org/10.1016/S0140-6736(19)32231-7

Farrell M; Martin NK; Stockings E; Bórquez A; Cepeda JA; Degenhardt L; Ali R; Tran LT; Rehm J; Torrens M; Shoptaw S; McKetin R, 2019, 'Responding to global stimulant use: challenges and opportunities', The Lancet, 394, pp. 1652 - 1667, http://dx.doi.org/10.1016/S0140-6736(19)32230-5

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2019, 'Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia', Drug and Alcohol Dependence, 204, http://dx.doi.org/10.1016/j.drugalcdep.2019.107556

Darke S; Farrell M; Duflou J; Larance B; Lappin J, 2019, 'Circumstances of death of opioid users being treated with naltrexone', Addiction, 114, pp. 2000 - 2007, http://dx.doi.org/10.1111/add.14729

Clarke N; Vale G; Reeves EP; Kirwan M; Smith D; Farrell M; Hurl G; McElvaney NG, 2019, 'GDPR: an impediment to research?', IRISH JOURNAL OF MEDICAL SCIENCE, 188, pp. 1129 - 1135, http://dx.doi.org/10.1007/s11845-019-01980-2

McKetin R; Leung J; Stockings E; Huo Y; Foulds J; Lappin JM; Cumming C; Arunogiri S; Young JT; Sara G; Farrell M; Degenhardt L, 2019, 'Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis', EClinicalMedicine, 16, pp. 81 - 97, http://dx.doi.org/10.1016/j.eclinm.2019.09.014

Degenhardt L; Wolfe D; Hall W; Hickman M; Chang J; Bruneau J; Farrell M; Griffiths P, 2019, 'Strategies to reduce drug-related harm: responding to the evidence base', The Lancet, 394, pp. 1490 - 1493, http://dx.doi.org/10.1016/S0140-6736(19)32232-9

Stockings E; Tran LT; Santo T; Peacock A; Larney S; Santomauro D; Farrell M; Degenhardt L, 2019, 'Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis', Addiction, 114, pp. 1738 - 1750, http://dx.doi.org/10.1111/add.14706

Farrell MP; Yi CC, 2019, 'Sociological Perspectives on Contemporary Taiwanese Families', Journal of Family Issues, 40, pp. 1887 - 1895, http://dx.doi.org/10.1177/0192513X19863195

Darke S; Duflou J; Kaye S; Farrell M; Lappin J, 2019, 'Psychostimulant Use and Fatal Stroke in Young Adults', Journal of Forensic Sciences, 64, pp. 1421 - 1426, http://dx.doi.org/10.1111/1556-4029.14056

Farrell M; Marconi T; Getchell J; Green R; Cipolle M; Sixta S, 2019, 'The "Death Diamond": Death Beyond Trauma', AMERICAN SURGEON, 85, pp. 757 - 760, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000480412200038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisev N; Bharat C; Larney S; Dobbins T; Weatherburn D; Hickman M; Farrell M; Degenhardt L, 2019, 'The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study', The Lancet Public Health, 4, pp. e334 - e342, http://dx.doi.org/10.1016/S2468-2667(19)30060-X

Farrell M; Spencer A; Gbadebo A; Zhang Z; Halbert C, 2019, 'Brief Reports', AMERICAN SURGEON, 85, pp. 561 - 562, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000468880100036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Darke S; Duflou J; Kaye S; Farrell M; Lappin J, 2019, 'Body mass index and fatal stroke in young adults: A national study', Journal of Forensic and Legal Medicine, 63, pp. 1 - 6, http://dx.doi.org/10.1016/j.jflm.2019.02.003

Murawski S; Farrell M; Cordeiro-Rudnisky F; Blinkhorn R, 2019, 'Disseminated blastomycosis presenting as a retro-orbital mass', BMJ CASE REPORTS, 12, http://dx.doi.org/10.1136/bcr-2018-228681

Peacock A; Larance B; Bruno R; Pearson SA; Buckley NA; Farrell M; Degenhardt L, 2019, 'Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations', Addiction, 114, pp. 404 - 405, http://dx.doi.org/10.1111/add.14556

Peacock A; Larance B; Bruno R; Pearson SA; Buckley NA; Farrell M; Degenhardt L, 2019, 'Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting', Addiction, 114, pp. 389 - 399, http://dx.doi.org/10.1111/add.14380

Boland VC; Mattick RP; Siahpush M; Barker D; Doran CM; Martire KA; Bonevski B; McRobbie H; Borland R; Farrell M; West R; Courtney RJ, 2019, 'Factors associated with Quitline and pharmacotherapy utilisation among low-socioeconomic status smokers', Addictive Behaviors, 89, pp. 113 - 120, http://dx.doi.org/10.1016/j.addbeh.2018.09.029

Grebely J; Larney S; Peacock A; Colledge S; Leung J; Hickman M; Vickerman P; Blach S; Cunningham EB; Dumchev K; Lynskey M; Stone J; Trickey A; Razavi H; Mattick RP; Farrell M; Dore GJ; Degenhardt L, 2019, 'Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs', Addiction, 114, pp. 150 - 166, http://dx.doi.org/10.1111/add.14393

Hemingway M; Levine WC; Parmar A; Farrell M; Thomas MD; Ferguson J; George E, 2019, 'Investigation of healthcare professionals’ knowledge of actions during an active shooter event', Perioperative Care and Operating Room Management, 16, pp. 100078 - 100078, http://dx.doi.org/10.1016/j.pcorm.2019.100078

Darke S; Farrell M, 2018, 'Burroughs’ ‘Letter from a master addict to dangerous drugs’: a forgotten classic', Addiction, 113, pp. 2305 - 2308, http://dx.doi.org/10.1111/add.14391

Reilly DEO; Dooley L; Watson G; Clarke R; Nolan A; Nolan C; Berkeley E; Farrell MP; Gallagher D, 2018, 'BRCA1/BRCA2 predictive genetic testing in an Irish population: A missed opportunity', ANNALS OF ONCOLOGY, 29, pp. 78 - 78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000459277300242&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Peacock A; Leung J; Larney S; Colledge S; Hickman M; Rehm J; Giovino GA; West R; Hall W; Griffiths P; Ali R; Gowing L; Marsden J; Ferrari AJ; Grebely J; Farrell M; Degenhardt L, 2018, 'Global statistics on alcohol, tobacco and illicit drug use: 2017 status report', Addiction, 113, pp. 1905 - 1926, http://dx.doi.org/10.1111/add.14234

Thomas T; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn C; Hall W; Paul C; Zwar N; Ferguson S; Veronica B; Richmond R; Doran C; Shakeshaft A; Mattick R; Courtney R; Thomas D; Boland V, 2018, 'The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial', Addiction, 114, pp. 923 - 933, http://dx.doi.org/10.1111/add.14541

Dewald EL; Tommasini R; Meezan NB; Landen OL; Khan S; Rygg R; Field J; Moore AS; Sayre D; MacKinnon AJ; Berzak Hopkins LF; Divol L; Le Pape S; Pak A; Thomas CA; Farrell M; Nikroo A; Hurricane O, 2018, 'First demonstration of improved capsule implosions by reducing radiation preheat in uranium vs gold hohlraums', Physics of Plasmas, 25, http://dx.doi.org/10.1063/1.5039385

Hall WD; Farrell M, 2018, 'The challenges in providing safe, effective, affordable cannabis-based medicines for unapproved indications', Medical Journal of Australia, 209, pp. 209 - 210, http://dx.doi.org/10.5694/MJA18.00445

Hobden B; Bryant J; Carey M; Baker AL; Farrell M; Oldmeadow C; Mattick RP; Shakeshaft A; Sanson-Fisher R, 2018, 'Finding the optimal treatment model: A systematic review of treatment for co-occurring alcohol misuse and depression', Australian and New Zealand Journal of Psychiatry, 52, pp. 737 - 750, http://dx.doi.org/10.1177/0004867418758922

Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L, 2018, 'Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study', The Lancet Public Health, 3, pp. e341 - e350, http://dx.doi.org/10.1016/S2468-2667(18)30110-5

Stockings E; Zagic D; Campbell G; Weier M; Hall WD; Nielsen S; Herkes GK; Farrell M; Degenhardt L, 2018, 'Evidence for cannabis and cannabinoids for epilepsy: A systematic review of controlled and observational evidence', Journal of Neurology, Neurosurgery and Psychiatry, 89, pp. 741 - 753, http://dx.doi.org/10.1136/jnnp-2017-317168

Hall WD; Farrell M, 2018, 'Reducing the opioid overdose death toll in North America', PLoS Medicine, 15, http://dx.doi.org/10.1371/journal.pmed.1002626

Stockings E; Shakeshaft A; Farrell M, 2018, 'Community Approaches for Reducing Alcohol-Related Harms: an Overview of Intervention Strategies, Efficacy, and Considerations for Future Research', Current Addiction Reports, 5, pp. 274 - 286, http://dx.doi.org/10.1007/s40429-018-0210-2

Lappin JM; Darke S; Farrell M, 2018, 'Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications', Drug and Alcohol Dependence, 187, pp. 134 - 140, http://dx.doi.org/10.1016/j.drugalcdep.2018.02.032

Back to profile page